Fund Holdings — Vestal Point Capital, LP

Total Portfolio Value
$2.20B
Total Bought
$952.61M
Total Sold
$733.71M
Net Transaction
+$218.90M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Abivax SA(ABVX)01,000,000+1,000,000084,9003.85%+84,900
Ascendis Pharma A/S(ASND)200,000600,000+400,00034,520119,2865.41%+84,766
Becton Dickinson & Co(BDX)25,000325,000+300,0004,30660,8302.76%+56,524
Repligen Corp(RGEN)0400,000+400,000053,4682.43%+53,468
Ionis Pharmaceuticals Inc(IONS)500,0001,075,000+575,00019,75570,3273.19%+50,572
Dexcom Inc(DXCM)0650,000+650,000043,7391.98%+43,739
Globus Medical Inc(GMED)500,0001,250,000+750,00029,51071,5883.25%+42,078
Biogen Inc(BIIB)0275,000+275,000038,5221.75%+38,522
Alcon AG(ALC)525,0001,100,000+575,00046,34781,9613.72%+35,614
Bicara Therapeutics Inc5,000,0005,100,000+100,00046,45080,5293.65%+34,079
Rapport Therapeutics Inc(RAPP)0950,000+950,000028,2151.28%+28,215
Dyne Therapeutics Inc(DYN)727,5002,775,000+2,047,5006,92635,1041.59%+28,178
Disc Medicine Inc(IRON)140,000500,000+360,0007,41433,0401.50%+25,626
Belite Bio Inc(BLTE)0312,500+312,500023,1251.05%+23,125
Ultragenyx Pharmaceutical Inc(RARE)0750,000+750,000022,5601.02%+22,560
Immatics NV(IMTX)6,250,0006,350,000+100,00033,62554,1022.45%+20,477
Danaher Corp(DHR)50,000150,000+100,0009,87729,7391.35%+19,862
Enliven Therapeutics Inc250,0001,160,000+910,0005,01523,7451.08%+18,730
Axsome Therapeutics Inc(AXSM)0150,000+150,000018,2180.83%+18,218
BioMarin Pharmaceutical Inc(BMRN)500,000830,000+330,00027,48544,9532.04%+17,468
Apogee Therapeutics Inc(APGE)0425,000+425,000016,8850.77%+16,885
Zymeworks Inc(ZYME)1,150,0001,765,000+615,00014,43330,1461.37%+15,714
Regeneron Pharmaceuticals Inc(REGN)025,000+25,000014,0570.64%+14,057
Cidara Therapeutics Inc500,000400,000-100,00024,35538,3041.74%+13,949
Nuvalent Inc1,075,0001,100,000+25,00082,02395,1284.32%+13,106
Astria Therapeutics Inc4,522,0004,956,000+434,00024,23836,0801.64%+11,842
Taysha Gene Therapies Inc(TSHA)3,000,0005,500,000+2,500,0006,93017,9850.82%+11,055
Solid Biosciences Inc1,505,0002,975,000+1,470,0007,32918,3560.83%+11,026
Inspire Medical Systems Inc(INSP)0135,000+135,000010,0170.45%+10,017
Abbott Laboratories175,000250,000+75,00023,80233,4851.52%+9,683
Nurix Therapeutics Inc(NRIX)2,000,0003,475,000+1,475,00022,78032,1091.46%+9,329
Amicus Therapeutics Inc
COM
11,900,0009,750,000-2,150,00068,18776,8303.49%+8,643
Lexeo Therapeutics Inc(LXEO)3,228,1613,250,000+21,83912,97721,5800.98%+8,603
Tyra Biosciences Inc(TYRA)2,655,0002,425,000-230,00025,40833,9261.54%+8,517
Black Diamond Therapeutics Inc5,600,0005,550,000-50,00013,88821,0350.95%+7,147
CG Oncology Inc(CGON)0175,000+175,00007,0490.32%+7,049
Tvardi Therapeutics Inc(TVRD)0167,000+167,00006,5080.30%+6,508
Monte Rosa Therapeutics Inc(GLUE)0800,000+800,00005,9280.27%+5,928
GSK PLC(GSK)0125,000+125,00005,3950.24%+5,395
Novocure Ltd(NVCR)0400,000+400,00005,1680.23%+5,168
Agios Pharmaceuticals Inc(AGIO)0127,000+127,00005,0980.23%+5,098
Applied Therapeutics Inc11,500,00014,250,000+2,750,0003,5788,6200.39%+5,042
Lantheus Holdings Inc(LNTH)50,000170,000+120,0004,0938,7190.40%+4,626
Myriad Genetics Inc(MYGN)0600,000+600,00004,3380.20%+4,338
Establishment Labs Holdings In(ESTA)0100,000+100,00004,0990.19%+4,099
Kodiak Sciences Inc(KOD)0250,000+250,00004,0930.19%+4,093
Beta Bionics Inc(BBNX)550,000600,000+50,0008,00811,9220.54%+3,914
Arcus Biosciences Inc(RCUS)0250,000+250,00003,4000.15%+3,400
Scholar Rock Holding Corp(SRRK)1,500,0001,500,000053,13055,8602.53%+2,730
Passage Bio Inc(PASG)0305,000+305,00002,4490.11%+2,449
Arcutis Biotherapeutics Inc(ARQT)95,000200,000+105,0001,3323,7700.17%+2,438
Voyager Therapeutics Inc(VYGR)1,475,0001,475,00004,5876,8880.31%+2,301
Ventyx Biosciences Inc2,000,0002,050,000+50,0004,2806,3760.29%+2,096
Alto Neuroscience Inc(ANRO)950,000950,00002,0903,8190.17%+1,729
Alector Inc976,992980,000+3,0081,3682,9010.13%+1,533
Pulmonx Corp(LUNG)0830,000+830,00001,3450.06%+1,345
Engene Holdings Inc
COM
370,000370,00001,3472,5270.11%+1,180
Sutro Biopharma Inc(STRO)2,600,0002,600,00001,8562,2580.10%+402
Fate Therapeutics Inc(FATE)2,515,0002,515,00002,8173,1690.14%+352
OnKure Therapeutics Inc(OKUR)635,000635,00001,5181,7460.08%+229
MacroGenics Inc(MGNX)280,000280,00003394700.02%+132
Tenax Therapeutics Inc(TENX)53,43953,43903084070.02%+99
Traws Pharma Inc(TRAW)149,800150,000+2002222780.01%+56
Day One Biopharmaceuticals Inc
COM
3,000,0002,675,000-325,00019,50018,8590.86%-641
Atara Biotherapeutics Inc94,0850-94,0857260—-726
Viridian Therapeutics Inc(VRDN)100,0000-100,0001,3980—-1,398
Passage Bio Inc(PASG)6,100,0000-6,100,0002,4420—-2,442
Neurocrine Biosciences Inc(NBIX)30,0000-30,0003,7710—-3,771
Celldex Therapeutics Inc(CLDX)1,750,0001,205,000-545,00035,61331,1731.41%-4,439
Zimmer Biomet Holdings Inc(ZBH)50,0000-50,0004,5610—-4,560
Travere Therapeutics Inc(TVTX)355,0000-355,0005,2540—-5,254
Nyxoah SA
SHS
1,402,0021,107,413-294,58910,4875,0940.23%-5,393
Bruker Corp(BRKR)500,000440,000-60,00020,60014,2960.65%-6,304
Geron Corp(GERN)23,775,00017,225,000-6,550,00033,52323,5981.07%-9,924
Thermo Fisher Scientific Inc(TMO)25,0000-25,00010,1370—-10,136
Savara Inc(SVRA)11,015,0004,015,000-7,000,00025,11414,3340.65%-10,781
Crinetics Pharmaceuticals Inc(CRNX)1,500,000750,000-750,00043,14031,2381.42%-11,902
Dianthus Therapeutics Inc(DNTH)3,200,0001,180,000-2,020,00059,61646,4332.11%-13,183
Revolution Medicines Inc(RVMD)1,200,000630,000-570,00044,14829,4211.33%-14,727
Perrigo Co PLC(PRGO)625,0000-625,00016,7000—-16,700
Medtronic PLC(MDT)195,0000-195,00016,9980—-16,998
Xenon Pharmaceuticals Inc(XENE)2,000,0001,100,000-900,00062,60044,1652.00%-18,435
Cogent Biosciences Inc(COGT)3,080,0000-3,080,00022,1140—-22,114
Edwards Lifesciences Corp300,0000-300,00023,4630—-23,463
Structure Therapeutics Inc1,200,0000-1,200,00024,8880—-24,888
Cooper Cos Inc/The(COO)350,0000-350,00024,9060—-24,906
MoonLake Immunotherapeutics(MLTX)550,0000-550,00025,9600—-25,960
Exact Sciences Corp(EXK)700,00075,000-625,00037,1984,1030.19%-33,095
uniQure NV(QURE)3,700,000225,000-3,475,00051,57813,1330.60%-38,445
KalVista Pharmaceuticals Inc4,675,000750,000-3,925,00052,8519,1350.41%-43,716
Vera Therapeutics Inc(VERA)3,100,000760,000-2,340,00073,03622,0861.00%-50,950
GE HealthCare Technologies Inc(GEHC)700,0000-700,00051,8490—-51,849
Cytokinetics Inc(CYTK)2,975,000725,000-2,250,00098,29439,8461.81%-58,448
Jazz Pharmaceuticals PLC(JAZZ)1,200,000500,000-700,000127,34465,9002.99%-61,444
Arcellx Inc
COMMON STOCK
2,750,0001,250,000-1,500,000181,088102,6254.66%-78,462
Page 1 of 1
Vestal Point Capital, LP — 13F Holdings — Q3 2025 | TickerTrail